Benferol 800 IU Norsko - norština - Statens legemiddelverk

benferol 800 iu

consilient health limited - kolekalsiferol - kapsel, myk - 800 iu

Benferol 5600 IU Norsko - norština - Statens legemiddelverk

benferol 5600 iu

consilient health limited - kolekalsiferol - kapsel, myk - 5600 iu

Neo-Mercazole 5 mg Norsko - norština - Statens legemiddelverk

neo-mercazole 5 mg

amdipharm limited - karbimazol - tablett, drasjert - 5 mg

Ovesterin 0.1 % Norsko - norština - Statens legemiddelverk

ovesterin 0.1 %

aspen pharma trading limited - Østriol - vaginalkrem - 0.1 %

Ovesterin 0.5 mg Norsko - norština - Statens legemiddelverk

ovesterin 0.5 mg

aspen pharma trading limited - Østriol - vagitorie - 0.5 mg

Vazkepa Evropská unie - norština - EMA (European Medicines Agency)

vazkepa

amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidemiene - lipid modifiserende midler - indicated to reduce cardiovascular risk as an adjunct to statin therapy.

Xevudy Evropská unie - norština - EMA (European Medicines Agency)

xevudy

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immune sera og immunglobuliner, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

Kauliv Evropská unie - norština - EMA (European Medicines Agency)

kauliv

strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalsiumhomeostase - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Trobalt Evropská unie - norština - EMA (European Medicines Agency)

trobalt

glaxo group limited  - retigabin - epilepsi - antiepileptics, - trobalt angis som tilleggsbehandling behandling av stoff-resistent delvis-utbruddet anfall med eller uten sekundær generalisering hos pasienter 18 år eller eldre med epilepsi, der andre aktuelle rusmiddelkombinasjoner har vist seg utilstrekkelig eller er ikke tolerert.

Xaluprine (previously Mercaptopurine Nova Laboratories) Evropská unie - norština - EMA (European Medicines Agency)

xaluprine (previously mercaptopurine nova laboratories)

nova laboratories ireland limited - 6-merkaptopurinmonohydrat - leukemi, lymfoid - antineoplastiske midler - xaluprine er indisert for behandling av akutt lymfoblastisk leukemi (all) hos voksne, ungdom og barn.